Core Insights - Guardian Pharmacy Services reported a strong quarterly earnings performance, leading to a significant increase in its stock price, outperforming the S&P 500 index [1][5] Financial Performance - The company achieved a 20% year-over-year revenue increase, totaling over $377 million, driven by a 13% rise in total residents served, reaching 204,000 [2] - Guardian's net income, not according to GAAP, was $15.7 million, a notable improvement from the previous year's breakeven result [3] - The average analyst estimate for Guardian's third-quarter revenue was $354 million, indicating a solid performance above expectations [4] Management Outlook - CEO Fred Burke expressed confidence in the company's business model, highlighting the combination of local expertise with national resources [5] - The company raised its full-year 2025 revenue guidance to a range of $1.43 billion to $1.45 billion, up from the previous range of $1.39 billion to $1.41 billion [6][7] - Adjusted EBITDA guidance was also increased to $104 million to $106 million, compared to the prior range of $100 million to $102 million [7]
Why Guardian Pharmacy Services Stock Was on a Tear Tuesday